vulnificus components with pattern recognition receptors (PRRs) (Espat et al., 1996; Powell et al., 1997, 2003; Shin et al., 2002; Lu et al., 2009). Recent studies showed that recombinant-produced V. vulnificus lipoprotein (Ilpa) and flagellar filament protein (FlaB) are recognized by Toll-like receptor 2 (TLR2) and TLR5, respectively (Lee et al., 2006; Goo et al., 2007). TLRs are a family of PRRs that are among the first line of host defense (Takeda & Akira, 2005; Gerold et al., 2007). Upon recognition of agonists, TLRs associate with central adapter

molecules such as myeloid differentiation factor 88 (MyD88). This interaction initiates a signaling cascade that results in production of TNFα and other proinflammatory cytokines. Although selleck compound library TLR signaling is usually essential for activating an effective host immune response, it also plays a lead role in induction of the systemic inflammatory response that causes septic shock (Leaver et al., 2007). Thus, TLRs have attracted attention as this website targets for treatment of sepsis. However, blockade of harmful TLR signaling requires knowledge of the TLR repertoire activated by a pathogen and the effect of TLR signaling on the host response and the outcome of infection (Gao et al., 2008). In addition to TLR2 and TLR5 agonists, V. vulnificus synthesizes lipopolysaccharide, which elicits a proinflammatory

cytokine response (e.g. TNFα secretion and cytokine mRNA expression) from human peripheral blood monocytes (Powell et al., 1997). Many Gram-negative bacteria activate TLR signaling due to recognition of their lipopolysaccharide via TLR4 (Takeda & Akira, 2005; Gerold et al., 2007). However, there was no information concerning whether V. vulnificus activates TLR4.

The goal of this study was to investigate the role of TLR4 in the host response to V. vulnificus using mice that are genetically deficient for this receptor. Wild-type (WT) male C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME). Homozygous TLR4 knockout (KO) (Hoshino et al., 1999) and MyD88 KO (Adachi Fossariinae et al., 1998) mice that had been backcrossed for eight generations to WT mice were obtained via S. Akira (Osaka, Japan). Homozygous TNFα KO mice generated on a C57BL/6 background were obtained via L. Old (New York, NY). All mice were housed under specific pathogen-free conditions. MyD88 KO mice were reared without antibiotics and received sterile water and food. Animal procedures were approved by the University of North Carolina at Chapel Hill (UNC-CH) Institutional Animal Care and Use Committee. Vibrio vulnificus type strain ATCC 27562, a clinical (blood) isolate, was purchased from Remel (Lake Charles, LA) and grown in Bacto heart infusion (HI) broth (Becton Dickinson and Co., Sparks, MD) or on HI agar. Stocks were prepared by addition of glycerol (10% final concentration) to broth cultures and stored at −70 °C. Inactivated V.